Domain Therapeutics

Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology.

Latest funding

$41M Series A · May 10, 2022

Website: domaintherapeutics.com.

X: @DOMAINtx · 343 followers.

LinkedIn: domain-therapeutics.

Category: Health and bio.

Stage: Series A.

Last round: May 10, 2022 · 1,647 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

X account@DOMAINtx · created Dec 3, 2012 (13 years old) · 343 followers

Website registeredOct 25, 2008 (18 years old)

About Domain Therapeutics

Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/domain-therapeutics (get a free API key).